Evaluation of Viloxazine and Its Metabolite 5-Hydroxy-viloxazine Glucuronide Into Breast Milk in Healthy Lactating Women
Clinical trial NCT06259331 · COMPLETED
Trial details
- NCT number
- NCT06259331
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-23
- Primary completion
- 2023-09-20
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.